tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mara Goldstein, 131 are a BUY (75.72%), 40 are a HOLD (23.12%), 2 are a SELL (1.16%).
Analyst Mara Goldstein, currently employed at MIZUHO, carries an average stock price target met ratio of 43.73% that have a potential upside of 37.16% achieved within 238 days.
Mara Goldstein’s has documented 322 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on VSTM, Verastem at 19-Dec-2024.
Analyst best performing recommendations are on FTSV (FORTY SEVEN).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 3/30/2023. The price target of $3.5 was fulfilled within 69 days with a profit of $2.71 (343.04%) receiving and performance score of 49.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$101
$-7.24 (-6.69%)
$101
5 years 1 months 23 days ago
(01-Nov-2019)
2/8 (25%)
$-7.53 (-6.94%)
171
Hold
$115
$6.76 (6.25%)
$102
5 years 1 months 23 days ago
(01-Nov-2019)
3/12 (25%)
$6.47 (5.96%)
382
Hold
$100
$-8.24 (-7.61%)
$128
5 years 4 months 5 days ago
(19-Aug-2019)
3/6 (50%)
$4.78 (5.02%)
159
Buy
$102
$-6.24 (-5.76%)
$105
5 years 7 months 21 days ago
(03-May-2019)
3/3 (100%)
$5.12 (5.28%)
270
Hold
$100
$-8.24 (-7.61%)
$100
5 years 8 months 19 days ago
(05-Apr-2019)
2/7 (28.57%)
$5.2 (5.49%)
282
Which stock is Mara Goldstein is most bullish on?
What Year was the first public recommendation made by Mara Goldstein?
